To the Editor:
We have read with great interest the original article written by de Boysson, et al1. This multicenter retrospective study highlighted the vasculitic-related risk of stroke in patients with newly diagnosed giant cell arteritis (GCA) and how it was related to ophthalmic ischemic impairment and to lower systemic inflammatory markers (i.e., lower acute-phase proteins level and lower risk of anemia) in comparison with GCA patients without stroke. Concerning this, in our cohort of 82 patients with a GCA diagnosis according to the 1990 American College of Rheumatology criteria, 6 (mean age at diagnosis 73.5 ± 8.89 yrs; …
Address correspondence to Dr. G. Vitiello, Experimental and Clinical Medicine Department, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50123 Florence, Italy. E-mail: vit.gianfranco{at}gmail.com